Inventor
COLLINS FRANCIS S
US30 patents
⚠️ This page may combine multiple inventors who share the name “COLLINS FRANCIS S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
US HEALTH
9 patentsUS6013449AJan 11, 2000
Probe-based analysis of heterozygous mutations using two-color labelling
US HEALTH133 citations97
US6342355B1Jan 29, 2002
Probe-based analysis of heterozygous mutations using two-color labelling
US HEALTH106 citations96
US8828356B2Sep 9, 2014
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
US HEALTH6 citations81
US7838531B2Nov 23, 2010
Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
US HEALTH6 citations71
US7297492B2Nov 20, 2007
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
US HEALTH5 citations69
US7358347B1Apr 15, 2008
MEN1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides and uses thereof
US HEALTH2 citations52
US8034557B2Oct 11, 2011
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
US HEALTH0 citations48
US9115400B2Aug 25, 2015
LMNA gene and its involvement in Hutchinson-Gilford Progeria Syndrome (HGPS) and arteriosclerosis
US HEALTH0 citations45
US6627745B1Sep 30, 2003
Pyrin gene and mutants thereof, which cause familial Mediterranean fever
US HEALTH1 citations38
UNIV MICHIGAN
7 patentsUS5240846AAug 31, 1993
Gene therapy vector for cystic fibrosis
UNIV MICHIGAN381 citations99
US6984487B1Jan 10, 2006
Cystic fibrosis gene
UNIV MICHIGAN20 citations91
US6902907B1Jun 7, 2005
Cystic fibrosis gene
UNIV MICHIGAN24 citations91
US5434086AJul 18, 1995
Method of testing potential cystic fibrosis treating compounds using cells in culture
UNIV MICHIGAN37 citations90
US5859195AJan 12, 1999
Neurofibromatosis gene
UNIV MICHIGAN9 citations68
US5837457ANov 17, 1998
Markers for detection of chromosome 16 rearrangements
UNIV MICHIGAN4 citations60
US6238861B1May 29, 2001
Neurofibromatosis gene
UNIV MICHIGAN3 citations57
SAREPTA THERAPEUTICS INC
5 patentsUS9833468B2Dec 5, 2017
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
SAREPTA THERAPEUTICS INC12 citations91
US9326992B2May 3, 2016
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
SAREPTA THERAPEUTICS INC16 citations91
US10822608B2Nov 3, 2020
Oligonucleotide analogues targeting human LMNA
SAREPTA THERAPEUTICS INC2 citations71
US11802283B2Oct 31, 2023
Oligonucleotide analogues targeting human LMNA
SAREPTA THERAPEUTICS INC0 citations61
US10398721B2Sep 3, 2019
Methods for treating progeroid laminopathies using oligonucleotide analogues targeting human LMNA
SAREPTA THERAPEUTICS INC0 citations50